Allena Pharmaceuticals Stock Target Price and Analyst Consensus

ALNA
 Stock
  

USD 0.12  0.01  7.69%   

The current analyst and expert consensus on Allena Pharmaceuticals is Strong Buy, with 0 strong sell and 4 strong buy opinions. The current projected Allena Pharmaceuticals target price consensus is 5.06 with 4 analyst opinions. The most common way Allena Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Allena Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Allena Pharmaceuticals. We encourage you to use your own analysis of Allena Pharmaceuticals to validate this buy or sell advice. Allena Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Allena Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 4.165. Please continue to Macroaxis Advice on Allena Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Allena Pharmaceuticals Interest Expense is projected to increase significantly based on the last few years of reporting. The past year's Interest Expense was at 976,000. The current year Weighted Average Shares is expected to grow to about 73.3 M, whereas Consolidated Income is forecasted to decline to (52.5 M).

Allena Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Allena target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Allena target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions4
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Allena analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Allena stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Allena Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Allena Pharmaceuticals Target Price Projection

Allena Pharmaceuticals' current and average target prices are 0.12 and 5.06, respectively. The current price of Allena Pharmaceuticals is the price at which Allena Pharmaceuticals is currently trading. On the other hand, Allena Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Allena Pharmaceuticals Market Quote on 15th of August 2022

Low Price0.11Odds
High Price0.13Odds

0.12

Target Price

Analyst Consensus On Allena Pharmaceuticals Target Price

Low Estimate1.25Odds
High Estimate11.0Odds
Number of Analysts4
Standard Deviation4.165

5.062

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Allena Pharmaceuticals and the information provided on this page.

Allena Pharmaceuticals Analyst Ratings

Allena Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Allena Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Allena Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Allena Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Allena Pharmaceuticals Target Price Projections

Allena Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Allena Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Allena depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Allena Pharmaceuticals including its fundamental analysis.

Additional Allena Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Allena Pharmaceuticals is a key component of Allena Pharmaceuticals valuation and have some predictive power on the future returns of a Allena Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Allena Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Allena Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.010.1118.46
Details
Intrinsic
Valuation
LowReal ValueHigh
0.071.3619.71
Details
Naive
Forecast
LowNext ValueHigh
0.0032680.1618.52
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-0.77-0.76-0.74
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Allena Pharmaceuticals. Your research has to be compared to or analyzed against Allena Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Allena Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Allena Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Momentum
Invested few shares
Chemicals Makers
Invested over 40 shares
Software
Invested over 20 shares
Driverless Cars
Invested over 100 shares
Impulse
Invested over 100 shares
Giant Impact
Invested few shares
Trump Equities
Invested few shares
Artificial Intelligence
Invested few shares
Please continue to Macroaxis Advice on Allena Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Allena Pharmaceuticals information on this page should be used as a complementary analysis to other Allena Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Allena Stock analysis

When running Allena Pharmaceuticals price analysis, check to measure Allena Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allena Pharmaceuticals is operating at the current time. Most of Allena Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Allena Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Allena Pharmaceuticals' price. Additionally, you may evaluate how the addition of Allena Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
The data published in Allena Pharmaceuticals' official financial statements usually reflect Allena Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Allena Pharmaceuticals. For example, before you start analyzing numbers published by Allena accountants, it's critical to develop an understanding of what Allena Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Allena Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Allena Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Allena Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Allena Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Allena Pharmaceuticals' management to manipulate its earnings.